Uncategorized
Early tally on federal spending
admin | May 8, 2020
This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.
The Treasury expects to borrow an eye-popping $3 trillion in the current calendar quarter to fund spending enacted to cushion the economic blow from coronavirus. The Treasury’s daily financial statements show a significant portion of the money allocated in the $2.2 trillion CARES act was already spent in April.
CARES Act
The CARES act included an unprecedented response to the COVID crisis. An estimate by the Congressional Budget Office and the Congressional Joint Committee on Taxation pegged the impact on the deficit to be $1.8 trillion, including a whopping $1.6 trillion in fiscal year 2020 alone. The largest programs are the Payroll Protection Program, special unemployment benefits, household rebate checks and tax breaks for businesses primarily from a delay in payroll tax obligations and more generous allowances for operating losses. The CARES act also includes nearly a half trillion dollars to support Fed lending facilities, but these are estimated to have no substantial impact on the budget, as the Fed is not expected to lose money on the lending programs; Treasury will have to borrow to fund the equity support that it is offering to the Fed to backstop the facilities. Another key step taken by Treasury unilaterally that will have little impact on the annual deficit but heavily affected the April budget numbers is Treasury’s move to delay the April 15 tax date by three months to July 15.
April Treasury statement figures
The Treasury reports its monthly budget figures for April on May 12, but the daily Treasury statements offer a decent read on spending of COVID-related funds. Treasury spent $12.4 billion as part of its airline support program, $139.6 billion for coronavirus relief mostly as payments to hospitals and municipalities, and the Small Business Administration spent $13.6 billion in April, undoubtedly linked to the PPP. In addition, the bulk of the “recovery rebate” checks went out electronically in April, totaling about $150 billion.
Meanwhile, there are other existing spending categories that are surging sharply due to the virus response. Unemployment benefits from April 2019 to April 2020 surged from $2.5 billion to $48.4 billion. Medicare outlays year-over-year shot up by nearly $100 billion. Finally, the HHS budget increased year-over-year by nearly $40 billion, likely reflecting purchase of personal protective equipment and other medical supplies.
Finally, thanks to the 3-month delay in the tax date, nonwithheld individual and corporate income tax receipts likely sank in April by a combined $300 billion or so.
In all, the federal government provided total stimulus of $800 billion or so just in the month of April. The incremental amounts are likely to recede in May and the months ahead, but the largesse will remain substantial for the foreseeable future, especially if Congress eventually enacts a second CARES-style package.
This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.
Important Disclaimers
Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.
In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.
The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.
In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.
Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.
